Paragraph IV Disputes Master Symposium

American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

Brian Anderson
Vice President & Assistant General Counsel IP Litigation
Allergan

Adam Chiss
Division Counsel Intellectual Property Litigation
Abbvie

Debra Condino
Vice President, Intellectual Property
Sienna Biopharmaceuticals (Westlake Village, CA)

Ryan M. Daniel
Corporate Counsel
Fresenius Kabi USA, LLC

Stephanie Donahue
Senior Director, Patent Litigation
Sanofi

Guy Donatiello
Senior Vice President, Intellectual Property
Endo Pharmaceuticals (Malvern, PA)

Rekha Hanu, Ph.D, J.D
Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)

Brian Hirsch
Vice President Global IP and Legal Head North America
Glenmark Pharmaceuticals (Mahwah, NJ)

Amy Hulina
SVP, Intellectual Property
Amneal Pharmaceuticals

Andrea Hutchison
Associate General Counsel, IP Litigation
Gilead Sciences

Lisa A. Jakob
Legal Director, IP Litigation
Merck & Company (Rahway, NJ)

Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

James Kellerman
Vice President, Intellectual Property
Astellas Pharma US, Inc. (Northbrook, IL)

James P. Leeds
Assistant General Patent Counsel
Eli Lilly & Company (Indianapolis, IN)

Josephine Liu, Ph.D., J.D.
Head, US IP Litigation
Sandoz Inc. (Princeton, NJ)

Jennifer Grant Moitoso
Vice President, Regional Head of IP
Takeda (Lexington, MA)

Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel
Pfizer Inc (New York, NY)

Mark Rachlin
Senior Patent Counsel-Litigation
GlaxoSmithKline (King of Prussia, PA)

Carmen M. Shepard
Senior Vice President, Global Policy and Regulatory Counsel
Mylan (Washington, DC)

Pearl T. L. Siew
Senior Vice President and Head Intellectual Property
Eagle Pharmaceuticals, Inc (Woodcliff Lake, NJ)

Peter Waibel
Head, US Patent Litigation
Novartis Pharmaceuticals Corporation (East Hanover, NJ)

Kevin Zive
Vice President, Global Intellectual Property
Apotex (Toronto, ON, CA)

Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation Taft Stettinius & Hollister LLP (Chicago, IL) (Former Vice President, IP, Sandoz, Inc.)

George W. Johnston
Counsel,
Gibbons P.C. (Newark, NJ) (Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)

David H. Silverstein, M.S., J.D.
Partner
Axinn, Veltrop & Harkrider LLP (New York, NY) (Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)

Meg Snowden
Shareholder
Margaret M. Snowden, P.C. (San Francisco, CA) (Former Vice President,, Intellectual Property, Impax Laboratories)

Shashank Upadhye
Partner
Amin Talati & Upadhye (Chicago, IL) (Former Vice President – Global Intellectual Property, Apotex, Inc.)